TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23155696

Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Number of subjects: 58

Group type: COMPARATOR
Intervention: Hypocaloric diet
Number of subjects: 58
Study: 20100408

Group type: EXPERIMENTAL
Intervention: 0.3% nifedipine and 1.5% lidocaine ointment
Number of subjects: 270

Group type: COMPARATOR
Intervention: 1.5% lidocaine ointment alone
Number of subjects: 270
Study: 18517168

Group type: EXPERIMENTAL
Intervention: Patient positioning and timing during blood pressure measurement
Number of subjects: 0
Study: 15817854

Group type: EXPERIMENTAL
Intervention: bIg (5 g)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 12421061

Group type: EXPERIMENTAL
Intervention: Rapid serial visual presentation of 2 written words at 53 ms/item with varying stimulus onset asynchrony (SOA) from 0 to 213 ms.
Number of subjects: 0
Study: 10609394

Group type: EXPERIMENTAL
Intervention: Proximal adenosine infusion (108 to 3456 micrograms/min for 2 min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Distal adenosine infusion (108 to 3456 micrograms/min for 2 min)
Number of subjects: 8
Study: 8836079

Group type: EXPERIMENTAL
Intervention: Bone-patellar tendon-bone autograft with Kennedy ligament augmentation device
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bone-patellar tendon-bone autograft without Kennedy ligament augmentation device
Number of subjects: 100
Study: 1426214

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (A), 50-100 mg daily
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 85
Study: 3907864

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (Cy A)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Conventional treatments
Number of subjects: 69
Study: 31331234

Group type: EXPERIMENTAL
Intervention: Drift-adjusted A’Hern design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sargent and Goldberg design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulated designs
Number of subjects: 0
Study: 30672231

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial acupuncture stimulation (rTAS)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Conventional western medication (Diazepam, 2.5 mg/day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (starch capsule, once a day)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Conventional western medication (Diazepam)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (starch capsule)
Number of subjects: 90
Study: 27791225

Group type: EXPERIMENTAL
Intervention: Standard ONS (200ml, 300kcal, 20g protein)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Energy-dense, small volume ONS (125ml, 300kcal, 18g protein)
Number of subjects: 67
Study: 24842649

Group type: EXPERIMENTAL
Intervention: Bupropion (150/300 mg/day) + Duloxetine (60 to 120 mg/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo + Duloxetine (60 to 120 mg/day)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Bupropion + Duloxetine
Number of subjects: 46
Study: 22161845

Group type: EXPERIMENTAL
Intervention: Perampanel 2 mg
Number of subjects: 1514

Group type: EXPERIMENTAL
Intervention: Perampanel 4 mg
Number of subjects: 1514

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1514
Study: 19727980

Group type: EXPERIMENTAL
Intervention: Pregabalin (150 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 80
Study: 17324826

Group type: EXPERIMENTAL
Intervention: 1% topical minoxidil
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study: 16240515

Group type: EXPERIMENTAL
Intervention: Clindesse vaginal cream (single dose)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Cleocin vaginal cream (7 doses)
Number of subjects: 540
Study: 12181117

Group type: EXPERIMENTAL
Intervention: N(G)‐monomethyl‐L‐arginine (L‐NMMA)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 8
Study: 10981082

Group type: EXPERIMENTAL
Intervention: Moxonidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACE inhibitors (enalapril, captopril)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Beta-blockers (atenolol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium-channel blockers (long-acting nifedipine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diuretics (hydrochlorothiazide)
Number of subjects: 0
Study: 7817959

Group type: EXPERIMENTAL
Intervention: Extraction of four first premolars
Number of subjects: 91

Group type: COMPARATOR
Intervention: Nonextraction
Number of subjects: 91
Study: 2351368

Group type: EXPERIMENTAL
Intervention: Cyproheptadine (6 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DL Carnitine (1600 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7435899

Group type: EXPERIMENTAL
Intervention: Low spinal anaesthesia
Number of subjects: 183

Group type: COMPARATOR
Intervention: Pudendal nerve block
Number of subjects: 183
Study: 31159887

Group type: EXPERIMENTAL
Intervention: PermaNet 3.0 (n = 32)
Number of subjects: 5200

Group type: EXPERIMENTAL
Intervention: Olyset Plus (n = 20)
Number of subjects: 5200

Group type: COMPARATOR
Intervention: PermaNet 2.0 (n = 37)
Number of subjects: 5200

Group type: COMPARATOR
Intervention: Olyset Net (n = 15)
Number of subjects: 5200
Study: 28001301

Group type: EXPERIMENTAL
Intervention: TPF regimen (docetaxel, cisplatin, and 5‐fluorouracil)
Number of subjects: 231
Study: 25873046

Group type: EXPERIMENTAL
Intervention: Ban-Lan-Gen granules
Number of subjects: 177

Group type: COMPARATOR
Intervention: Oseltamivir
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 24090258

Group type: EXPERIMENTAL
Intervention: Topical decolonization with intranasal mupirocin twice daily plus 4% chlorhexidine gluconate body wash daily for 5 days before surgery
Number of subjects: 693

Group type: COMPARATOR
Intervention: Oral antibiotics (cephalexin) with statim pre- and postoperative doses
Number of subjects: 693
Study: 22117991

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 μg/kg i.v. over 10 min followed by 0.2 - 0.7 μg/kg per h continuous i.v. infusion)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Remifentanil (0.8 - 1.2 μg/kg i.v. over 1 min followed by 0.05 - 0.1 μg/kg i.v. per min)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 50
Study: 19249426

Group type: EXPERIMENTAL
Intervention: Bone marrow-derived progenitor cells (BMC)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 17084796

Group type: EXPERIMENTAL
Intervention: Abstinence goal selection during brief intervention
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Cutting down on drinking goal selection during brief intervention
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Participants who were abstinent at enrollment and chose to remain abstinent
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Recognition of situations putting them at risk for drinking and identifying alternatives to consumption
Number of subjects: 115
Study: 15020545

Group type: EXPERIMENTAL
Intervention: In-school intervention (three lessons each lasting 50 min)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Tailored out-of-school intervention (three tailored letters with smoking prevention messages)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combined in-school and out-of-school intervention
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 11327055

Group type: EXPERIMENTAL
Intervention: ePTFE combined with weekly repeated local application of minocycline ointment for 8 weeks after membrane placement
Number of subjects: 40

Group type: COMPARATOR
Intervention: ePTFE alone (control group)
Number of subjects: 40
Study: 9623035

Group type: EXPERIMENTAL
Intervention: Regular surveillance using a simple questionnaire administered by non-professional personnel (cases)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (controls)
Number of subjects: 142
Study: 7929726

Group type: EXPERIMENTAL
Intervention: Transvaginal pulsed colour Doppler ultrasound evaluation of the vessels surrounding the dominant follicle for blood flow impedance analysis
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Clonidine test to explore the ability of the pituitary to release growth hormone
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Detection of anti‐granulosa cell auto‐antibodies in blood using an enzyme‐linked immunosorbent assay (ELISA)
Number of subjects: 31
Study: 3791153

Group type: EXPERIMENTAL
Intervention: Hydrazine sulfate (60 mg, 3 times/d)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 29771382

Group type: EXPERIMENTAL
Intervention: Siblings Coping Together intervention (SibCT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Attention control (CG)
Number of subjects: 30
Study: 27267228

Group type: EXPERIMENTAL
Intervention: Intravenous TXA (1 g)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Topical TXA (1 g)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (no TXA)
Number of subjects: 120
Study: 25719988

Group type: EXPERIMENTAL
Intervention: Y-MPL
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: IR-MPL
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control (not applicable)
Number of subjects: 53
Study: 22993101

Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir monotherapy (mLPV/r)
Number of subjects: 93

Group type: COMPARATOR
Intervention: tenofovir/lamivudine/LPV/r (TDF/3TC/LPV/r)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: mLPV/r
Number of subjects: 93

Group type: COMPARATOR
Intervention: TDF/3TC/LPV/r
Number of subjects: 93
Study: 21207788

Group type: EXPERIMENTAL
Intervention: RelyX Unicem (RXU)
Number of subjects: 34

Group type: COMPARATOR
Intervention: RelyX Unicem with selective enamel etching (RXU+E)
Number of subjects: 34
Study: 18501329

Group type: EXPERIMENTAL
Intervention: Femtosecond laser surgery after RLE with multifocal IOL implantation
Number of subjects: 31
Study: 15791928

Group type: EXPERIMENTAL
Intervention: 5 mg melatonin
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 10 mg melatonin
Number of subjects: 8
Study: 12719501

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 354

Group type: COMPARATOR
Intervention: Consult-liaison care
Number of subjects: 354
Study: 10480714

Group type: EXPERIMENTAL
Intervention: CT examination for neurocysticercosis (NCC)
Number of subjects: 2723

Group type: EXPERIMENTAL
Intervention: EITB assay for neurocysticercosis (NCC)
Number of subjects: 2723

Group type: COMPARATOR
Intervention: CT examination in seizure-free random sample
Number of subjects: 2723

Group type: COMPARATOR
Intervention: EITB assay in seizure-free random sample
Number of subjects: 2723

Group type: COMPARATOR
Intervention: Comparison of epilepsy group vs random sample for CT diagnosis
Number of subjects: 2723

Group type: COMPARATOR
Intervention: Comparison of epilepsy group vs random sample for EITB results
Number of subjects: 2723
Study: 8524494

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (500 mg intravenously after haemodialysis, 1-3 times a week)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (7 patients with normal iron status and without resistance to erythropoietin)
Number of subjects: 4
Study: 1683190

Group type: EXPERIMENTAL
Intervention: Terfenadine, 120 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cetirizine, 10 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 649528

Group type: EXPERIMENTAL
Intervention: Behavioral counselling
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Client-centered counselling
Number of subjects: 12

Group type: COMPARATOR
Intervention: No counselling
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Teacher approval
Number of subjects: 12
Study: 31081008

Group type: EXPERIMENTAL
Intervention: Removable orthodontic device
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Fixed orthodontic device
Number of subjects: 25
Study: 26718638

Group type: EXPERIMENTAL
Intervention: Hamstring autograft
Number of subjects: 132

Group type: COMPARATOR
Intervention: Tibialis allograft
Number of subjects: 132
Study: 25327884

Group type: EXPERIMENTAL
Intervention: Sodium citrate (CIT) 900 mg kg(‐1)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 11
Study: 23859625

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 66
Study: 21196836

Group type: EXPERIMENTAL
Intervention: Manual toothbrushing with audiovisual instruction
Number of subjects: 16

Group type: COMPARATOR
Intervention: Powered toothbrushing
Number of subjects: 16

Group type: COMPARATOR
Intervention: Comparison of manual and powered toothbrushes
Number of subjects: 16
Study: 19124807

Group type: EXPERIMENTAL
Intervention: ABVD
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: BEACOPP
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: CEC
Number of subjects: 307
Study: 17314114

Group type: EXPERIMENTAL
Intervention: 1.0 kcal/ml nocturnal enteral feed (NEF)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 1.5 kcal/ml nocturnal enteral feed (NEF)
Number of subjects: 32
Study: 15526587

Group type: EXPERIMENTAL
Intervention: Concomitant chemo-radiotherapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 80
Study: 11518451

Group type: EXPERIMENTAL
Intervention: Desogestrel 75 microg/day
Number of subjects: 84

Group type: COMPARATOR
Intervention: Levonorgestrel 30 microg/day
Number of subjects: 84
Study: 9489937

Group type: EXPERIMENTAL
Intervention: 2 mg/kg oral caffeine
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: 4 mg/kg oral caffeine
Number of subjects: 93

Group type: COMPARATOR
Intervention: 0 mg/kg oral caffeine (control group)
Number of subjects: 93
Study: 7827353

Group type: EXPERIMENTAL
Intervention: Adequate glycaemic control after 6 and 12 months
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Diabetic patients before treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 10
Study: 2901252

Group type: EXPERIMENTAL
Intervention: Neuroleptic treatment (medication continued)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Drug-withdrawn patients (some clinically relapsed)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patients with TD
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nondyskinetic patients
Number of subjects: 100
Study: 29904989

Group type: EXPERIMENTAL
Intervention: 12-week theory-based and culturally tailored dietary change program
Number of subjects: 70
Study: 28794291

Group type: EXPERIMENTAL
Intervention: Allopurinol, 100 mg daily for 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27004309

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTxA) injection (20 IU, 0.2 ml)
Number of subjects: 33

Group type: COMPARATOR
Intervention: 0.9% NaCl solution injection (0.2 ml)
Number of subjects: 33
Study: 23094638

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg + Amlodipine 10 mg
Number of subjects: 1111
Study: 21193281

Group type: EXPERIMENTAL
Intervention: Experiential‐existential therapy groups
Number of subjects: 11

Group type: COMPARATOR
Intervention: Social support groups
Number of subjects: 11
Study: 18420776

Group type: EXPERIMENTAL
Intervention: Viewing fitness magazine for 30 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Viewing control magazine for 30 minutes
Number of subjects: 0
Study: 17182297

Group type: COMPARATOR
Intervention: Alendronate 10 mg/day (ALN)
Number of subjects: 1423

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day (RLX)
Number of subjects: 1423

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1423
Study: 15531679

Group type: EXPERIMENTAL
Intervention: Zinc + beta-carotene supplementation
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Beta-carotene + zinc supplementation
Number of subjects: 170

Group type: COMPARATOR
Intervention: Beta-carotene supplementation
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 170
Study: 11505331

Group type: EXPERIMENTAL
Intervention: STW‐5 (herbal preparation containing bitter candy tuft and other extracts)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: STW‐5‐S (modified preparation without bitter candy tuft)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: STW‐5
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: STW‐5‐S
Number of subjects: 60
Study: 9598454

Group type: EXPERIMENTAL
Intervention: CGP56697 (artemether/benflumetol)
Number of subjects: 287

Group type: COMPARATOR
Intervention: P/S (pyrimethamine/sulfadoxine)
Number of subjects: 287
Study: 7994892

Group type: EXPERIMENTAL
Intervention: Adenoidectomy with ventilation tube insertion
Number of subjects: 222

Group type: COMPARATOR
Intervention: Ventilation tube insertion alone
Number of subjects: 222
Study: 3046633

Group type: EXPERIMENTAL
Intervention: Ketanserin (20-40 mg twice a day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30799474

Group type: EXPERIMENTAL
Intervention: Multi Etchant (ME)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enamel Conditioner (EC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: K-etchant GEL (KE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (CT; AU without conditioner)
Number of subjects: 0
Study: 27853946

Group type: EXPERIMENTAL
Intervention: Low-concentration hypochlorous acid (HOCl) nasal irrigation for 8 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (saline) nasal irrigation for 8 weeks
Number of subjects: 43
Study: 25397352

Group type: EXPERIMENTAL
Intervention: ACC (accurate feedback of baseline)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: DEC (deceived feedback, 2% increase above baseline)
Number of subjects: 9

Group type: COMPARATOR
Intervention: BaseL (baseline performance)
Number of subjects: 9
Study: 25124695

Group type: EXPERIMENTAL
Intervention: Stepping Stones Triple P (SSTP)
Number of subjects: 89

Group type: COMPARATOR
Intervention: EI services as usual
Number of subjects: 89
Study: 20491814

Group type: EXPERIMENTAL
Intervention: Group A (lateral onlay block grafts)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Group D (interpositional bone blocks after LeFort I operation)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Group E (control, no bone augmentation)
Number of subjects: 35
Study: 18368011

Group type: EXPERIMENTAL
Intervention: Wearing gloves
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Eating strawberries
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no gloves)
Number of subjects: 44
Study: 17489080

Group type: EXPERIMENTAL
Intervention: Circumferential sequential gradient compression (CSG)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Posterior uniform compression device (PU)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Posterior sequential rapid gradient inflation device (PSR)
Number of subjects: 12
Study: 16301230

Group type: EXPERIMENTAL
Intervention: Clonidine 2 mug/kg
Number of subjects: 169
Study: 12394199

Group type: EXPERIMENTAL
Intervention: Salt tablets (approximately 700 mg/h of sodium)
Number of subjects: 38
Study: 9839775

Group type: EXPERIMENTAL
Intervention: Sleep-deprived EEG
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Computer-assisted ambulatory EEG
Number of subjects: 46
Study: 7816993

Group type: EXPERIMENTAL
Intervention: Individualized training at the ventilatory threshold level, walking four times a week at the heart rate corresponding to the metabolic level of ventilatory threshold.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Individualized training at the ventilatory threshold level.
Number of subjects: 20
Study: 2915315

Group type: EXPERIMENTAL
Intervention: Single goniotomy
Number of subjects: 7

Group type: COMPARATOR
Intervention: Two simultaneous goniotomies
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Use of Sodium hyaluronate (Healon)
Number of subjects: 7
Study: 31680011

Group type: EXPERIMENTAL
Intervention: Terlipressin for five days
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 31524133

Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA) therapy, up to 15 sessions over 4 months.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual stroke care (control group).
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA) therapy.
Number of subjects: 48
Study: 28578470

Group type: EXPERIMENTAL
Intervention: Below-elbow cast (BEC)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Above-elbow cast (AEC)
Number of subjects: 72
Study: 26109257

Group type: EXPERIMENTAL
Intervention: Uncooked corn starch (CS)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Modified corn starch (MCS)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Pasta meal
Number of subjects: 5
Study: 24215565

Group type: EXPERIMENTAL
Intervention: Artemisinin-naphthoquine (ANQ) - total target dose of 24.5 mg/kg (naphthoquine 7 mg/kg and artemisinin 17.5 mg/kg), once a day for three days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chloroquine-primaquine (CQ-PQ) - total CQ dose of 24 mg base/kg, once a day for three days plus PQ dose of 0.45 mg base/kg/day, once a day for eight days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Artemisinin-naphthoquine (ANQ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chloroquine-primaquine (CQ-PQ)
Number of subjects: 0
Study: 21365002

Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (HIV-seronegative subjects)
Number of subjects: 60
Study: 18226746

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 16549227

Group type: EXPERIMENTAL
Intervention: Caffeine 3mg/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Caffeine 5mg/kg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12657908

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical pharmacokinetic monitoring (CPM) of MMF
Number of subjects: 0